Sponsor intelligence · OTHER
Clinical trials sponsored by
Peking Union Medical College Hospital.
Real, source-linked trial activity for Peking Union Medical College Hospital: 20 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Aug 5, 2026. Source-linked, daily-refreshed.
N/A 6PHASE2 5NA 3PHASE1/PHASE2 2PHASE4 1PHASE2/PHASE3 1EARLY_PHASE1 1PHASE3 1
Newest Peking Union Medical College Hospital trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 6d ago | Development and Validation of a Risk Prediction Model for Cardiac Surg | N/A | NOT_YET_RECRUITING | ↗ |
| 6d ago | SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological Malignancies | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 7d ago | Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstit | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 7d ago | Clinical Study on ShouTai Pills for Improving Reduced Ovarian Reserve | NA | NOT_YET_RECRUITING | ↗ |
| 15d ago | A Randomized Controlled Trial of 3D Airway Reconstruction for Precise | NA | NOT_YET_RECRUITING | ↗ |
| 15d ago | Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonizat | Ph 4 | RECRUITING | ↗ |
| 21d ago | Bionic Balloon-assisted Delivery Technology on the Labor Process | NA | NOT_YET_RECRUITING | ↗ |
| 22d ago | Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and | Ph 2 | RECRUITING | ↗ |
| 28d ago | Study on the Application of Liquid Chromatography-Tandem Mass Spectrom | N/A | RECRUITING | ↗ |
| 28d ago | Early Identification and Diagnosis of BAD-related Stroke | N/A | RECRUITING | ↗ |
| 31d ago | MRG003 With Gemcitabine for Second-line Advanced PDAC | Ph 1/Ph 2 | NOT_YET_RECRUITING | ↗ |
| 36d ago | A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemoth | Ph 2 | RECRUITING | ↗ |
| 41d ago | Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer | N/A | RECRUITING | ↗ |
| 41d ago | Phase II Study of Trastuzumab Rezetecan Combined With Adebrelimab and | Ph 2 | RECRUITING | ↗ |
| 42d ago | Evaluation of the Efficacy and Safety of Compound Betamethasone in Pul | Ph 2/Ph 3 | NOT_YET_RECRUITING | ↗ |
| 45d ago | Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT | Ph 1/Ph 2 | RECRUITING | ↗ |
| 49d ago | Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLB | EARLY_Ph 1 | RECRUITING | ↗ |
| 50d ago | Hemodynamic Effects of Norepinephrine Reduction on Critical Closing Pr | N/A | RECRUITING | ↗ |
| 50d ago | Risk Factor Assessment for Acute Pulmonary Hypertension Crisis | N/A | NOT_YET_RECRUITING | ↗ |
| 50d ago | rhTPO + CsA vs CsA in the Treatment of LR-MDS With Thrombocytopenia | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Peking Union Medical College Hospital (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.